Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CATV
4Cable TV International
$0.00
$0.00
$0.00
$0.00
N/AN/A42.10 million shs17.92 million shs
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
$0.00
+60.0%
$0.00
$0.00
$0.11
N/AN/A1.47 million shs74,732 shs
Vifor Pharma AG stock logo
GNHAF
Vifor Pharma
$181.25
$181.25
$174.25
$183.50
N/AN/A100 shsN/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
$0.00
+2.2%
$0.00
$0.00
$0.01
N/AN/A136,907 shs30,157 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CATV
4Cable TV International
0.00%0.00%0.00%0.00%-76.00%
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
0.00%+700.00%+433.33%-81.82%-97.95%
Vifor Pharma AG stock logo
GNHAF
Vifor Pharma
0.00%0.00%0.00%0.00%0.00%
1933 Industries Inc. stock logo
TGIFF
1933 Industries
0.00%-14.55%+4.44%+38.24%-50.53%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CATV
4Cable TV International
N/AN/AN/AN/AN/AN/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/AN/AN/AN/AN/AN/AN/AN/A
Vifor Pharma AG stock logo
GNHAF
Vifor Pharma
N/AN/AN/AN/AN/AN/AN/AN/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CATV
4Cable TV International
0.00
N/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
0.00
N/AN/AN/A
Vifor Pharma AG stock logo
GNHAF
Vifor Pharma
0.00
N/AN/AN/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CATV
4Cable TV International
N/AN/AN/AN/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/AN/AN/AN/AN/AN/A
Vifor Pharma AG stock logo
GNHAF
Vifor Pharma
N/AN/AN/AN/AN/AN/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CATV
4Cable TV International
N/A-$0.01N/AN/AN/AN/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/AN/A0.00N/AN/AN/AN/AN/A
Vifor Pharma AG stock logo
GNHAF
Vifor Pharma
N/AN/A0.00N/AN/AN/AN/AN/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CATV
4Cable TV International
N/AN/AN/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/AN/AN/AN/AN/A
Vifor Pharma AG stock logo
GNHAF
Vifor Pharma
N/AN/AN/AN/AN/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
CATV
4Cable TV International
N/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/A
Vifor Pharma AG stock logo
GNHAF
Vifor Pharma
N/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
CATV
4Cable TV International
10N/AN/ANot Optionable
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
460N/AN/ANot Optionable
Vifor Pharma AG stock logo
GNHAF
Vifor Pharma
2,200N/AN/ANot Optionable
1933 Industries Inc. stock logo
TGIFF
1933 Industries
87N/AN/ANot Optionable

Recent News About These Companies

1933 sees uptick in revenue in Nevada
1933 Industries Announces First Quarter 2025 Financial Report
1933 Industries Appoints New CFO and VP Finance

4Cable TV International OTCMKTS:CATV

$0.0003 0.00 (0.00%)
As of 07/3/2025 12:39 PM Eastern

4Cable TV International, Inc. provides specialty solutions to the cable television sector. It offers a suite of products comprising RF to Fiber (RF2F), a proprietary line of coax-to-fiber taps that enables cable operators to reach homes within their franchise authorized area; PowerMiser, a circuitry, which allows a low current 1 GHz amplifier and/or line extender to be constructed with a decrease in current power requirements; RF over Glass (RFoG) signal distribution technology that combines the existing cable TV infrastructure with fiber optics to reach the home; and Node+0 application, which combines the RFoG technology platform with its PowerMiser engineering to take fiber signal. The company also provides SOLAR-CATV that utilizes solar power and helps the operator extend service to areas not presently served without adding power sources; and Dynamically Scalable Return technology, which allows nodes, R-ONU's (RFoG optical network units) to adjust their return bandwidth by changing the channel lineup at the head end, as well as repair, testing, and upgrade services. It markets and sells its products through a network of dealers in the United States and Canada primarily to independent cable TV operators, as well as to multiple system operators. 4Cable TV International, Inc. was incorporated in 2007 and is based in Conway, South Carolina.

4Front Ventures stock logo

4Front Ventures OTCMKTS:FFNTF

$0.0016 +0.00 (+60.00%)
As of 07/3/2025 11:42 AM Eastern

4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates through THC Cannabis and CBD Wellness segments. THC Cannabis segment engages in the cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third party retailers; and provision of ancillary services. This segment sells equipment, supplies, and intellectual property to cannabis producers; and leases real estate properties. The CBD Wellness segment sells non-THC hemp derived products. In addition, it operates dispensaries in the Massachusetts, Illinois, and Michigan primarily under the MISSION brand name. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.

Vifor Pharma stock logo

Vifor Pharma OTCMKTS:GNHAF

$181.25 0.00 (0.00%)
As of 10/21/2022

Vifor Pharma AG, a pharmaceutical company, focuses on the development, manufacture, and commercialization of pharmaceutical products in Switzerland, rest of Europe, the United States, and internationally. The company offers Ferinject/Injectafer, a solution of ferric carboxymaltose used for the treatment of iron deficiency and iron deficiency anemia; Maltofer, an oral iron polymaltose complex for infants, children, adolescents, and pregnant woman with iron deficiency; and Mircera, a long-acting erythropoiesis-stimulating agent (ESA) to treat symptomatic anemia associated with the chronic kidney disease (CKD).It also provides Retacrit, a short-acting ESA; Venofer, an intravenous iron sucrose used in the intravenous treatment of iron deficiency; and Velphoro, a non-calcium, iron-based chewable phosphate binder for the treatment of hyperphosphatemia in adults with CKD undergoing dialysis. In addition, the company offers Rayaldee, an orally administered, extended release formulation of calcifediol for the treatment of secondary hyperparathyroidism in patients with CKD; and Veltassa for the treatment of hyperkalemia in CKD and chronic heart failure patients. Further, it develops Vadadustat, an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of altitude on oxygen availability; Avacopan, an orally-administered, highly selective inhibitor of C5aR1 for the treatment of orphan and rare renal diseases;ANG-3777 for the treatment of transplant-associated acute kidney injury; Difelikefalin for the treatment for chronic kidney disease-associated pruritus; and VIT-2763 to treat beta-thalassemia. Vifor Pharma AG has a strategic partnership with Fresenius Kabi and Zeria Pharmaceutical. The company was founded in 1872 and is headquartered in Sankt Gallen, Switzerland. As of August 9, 2022, Vifor Pharma AG operates as a subsidiary of CSL Behring AG.

1933 Industries stock logo

1933 Industries OTCMKTS:TGIFF

$0.0047 +0.00 (+2.17%)
As of 07/3/2025 11:26 AM Eastern

1933 Industries Inc., together with its subsidiaries, engages in the cultivation and production of cannabis products in the United States. It operates in three segments: the Medical Segment, the Recreational Segment, and the CBD-Infused Products Segment. The company produces, packages, and markets cannabidiol (CBD)-infused products, including tinctures, vape pens and cartridges, lotions, pain creams, gummies, and capsules under the Canna Hemp and Canna Hemp X brand names. It also offers craft-style cannabis, infused pre-rolls, full spectrum oils, distillates, terpenes, and vaporizer products; and boutique concentrates, such as shatters, crumbles, batters, sugar waxes, diamonds, and cured and live resins under the AMA and Level X brand names. The company offers its products through retail dispensaries and retail outlets, as well as through its e-commerce platform. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. 1933 Industries Inc. is headquartered in Vancouver, Canada.